ESPR

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Esperion Therapeutics Inc

NASDAQ | ESPR

2.79

USD

$0.00

(

0.00%

)

At Close (As of Oct 21, 2025)

$653.18M

Market Cap

-

P/E Ratio

-0.55

EPS

$3.94

52 Week High

$0.69

52 Week Low

HEALTHCARE

Sector

ESPR Chart

Recent Chart
Price Action

ESPR Technicals

Tags:

ESPR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $264M
Total Revenue $332M
Cost Of Revenue $69M
Costof Goods And Services Sold $69M
Operating Income $54M
Selling General And Administrative $138M
Research And Development $46M
Operating Expenses $209M
Investment Income Net -
Net Interest Income -$59M
Interest Income -
Interest Expense $59M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $63K
Income Before Tax -$52M
Income Tax Expense -$52M
Interest And Debt Expense -
Net Income From Continuing Operations -$52M
Comprehensive Income Net Of Tax -
Ebit $7.5M
Ebitda $7.6M
Net Income -$52M

Revenue & Profitability

Earnings Performance

ESPR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $344M
Total Current Assets $338M
Cash And Cash Equivalents At Carrying Value $145M
Cash And Short Term Investments $145M
Inventory $94M
Current Net Receivables $80M
Total Non Current Assets $5.8M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $56K
Intangible Assets Excluding Goodwill $56K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $19M
Other Non Current Assets -
Total Liabilities $733M
Total Current Liabilities $246M
Current Accounts Payable $52M
Deferred Revenue -
Current Debt -
Short Term Debt $105M
Total Non Current Liabilities $486M
Capital Lease Obligations $5.3M
Long Term Debt $238M
Current Long Term Debt $55M
Long Term Debt Noncurrent -
Short Long Term Debt Total $591M
Other Current Liabilities $81M
Other Non Current Liabilities $246M
Total Shareholder Equity -$389M
Treasury Stock -
Retained Earnings -$1.6B
Common Stock $196K
Common Stock Shares Outstanding $187M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$24M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $63K
Capital Expenditures $317K
Change In Receivables -
Change In Inventory -$29M
Profit Loss -
Cashflow From Investment -$317K
Cashflow From Financing $86M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $0
Dividend Payout Common Stock $0
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$52M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $264M
Total Revenue $332M
Cost Of Revenue $69M
Costof Goods And Services Sold $69M
Operating Income $54M
Selling General And Administrative $138M
Research And Development $46M
Operating Expenses $209M
Investment Income Net -
Net Interest Income -$59M
Interest Income -
Interest Expense $59M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $63K
Income Before Tax -$52M
Income Tax Expense -$52M
Interest And Debt Expense -
Net Income From Continuing Operations -$52M
Comprehensive Income Net Of Tax -
Ebit $7.5M
Ebitda $7.6M
Net Income -$52M

ESPR News

ESPR Profile

Esperion Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Esperion Therapeutics, Inc. is a biopharmaceutical company focused on delivering innovative therapies for patients with elevated low-density lipoprotein cholesterol (LDL-C). Headquartered in Ann Arbor, Michigan, Esperion is committed to transforming the treatment landscape for cardiovascular disease by developing and commercializing novel lipid-lowering agents. With a robust pipeline and a strong emphasis on patient-centered solutions, the company is well-positioned to play a significant role in the management of dyslipidemia.

BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
NVDA
-0.81%
$181.16
GDXD
+28.69%
$0.86
AIRE
+61.36%
$0.72
BURU
-14.84%
$0.28
BITF
-9.83%
$4.49
PLUG
-8.23%
$3.12
ADAP
-17.62%
$0.04
T
-0.19%
$26.05
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
DNN
-7.16%
$2.72
BTG
-9.12%
$5.18
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.24%
$13.39
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
ETHD
-0.80%
$3.72
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
AMZN
+2.56%
$222.03
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
LAES
-5.86%
$6.10
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
RR
+1.25%
$5.63
SOUN
-4.35%
$18.23
BTBT
-8.29%
$3.87
VALE
-1.14%
$11.27
BBD
-2.36%
$3.30
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
MARA
-3.18%
$20.07
IREN
-6.79%
$55.19
RMBL
+60.50%
$3.21
DCGO
+24.16%
$1.49
HAL
+11.58%
$25.24
CJET
-20.45%
$0.08
AAL
+1.47%
$12.35
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
CLSK
-7.99%
$18.77
NOK
-2.27%
$5.58
DFLI
-3.96%
$1.21
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
AMC
+4.33%
$2.89
KO
+4.06%
$71.22
PBR
-1.11%
$11.56
SNAP
+1.55%
$7.85
ONDS
-7.46%
$7.19
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
SMCI
-0.39%
$54.82
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.83%
$152.00
RIVN
+0.91%
$13.20
GOOG
-2.20%
$251.34
PLTR
-0.04%
$181.51
BAC
-0.99%
$51.52
APLD
-9.35%
$32.54
EPWK
-8.71%
$0.07
RGTZ
+15.11%
$15.61
ETWO
0.00%
$3.30
MSN
+59.31%
$0.76
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
WTO
+2.93%
$0.06
KVUE
-0.20%
$14.93
BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
NVDA
-0.81%
$181.16
GDXD
+28.69%
$0.86
AIRE
+61.36%
$0.72
BURU
-14.84%
$0.28
BITF
-9.83%
$4.49
PLUG
-8.23%
$3.12
ADAP
-17.62%
$0.04
T
-0.19%
$26.05
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
DNN
-7.16%
$2.72
BTG
-9.12%
$5.18
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.24%
$13.39
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
ETHD
-0.80%
$3.72
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
AMZN
+2.56%
$222.03
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
LAES
-5.86%
$6.10
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
RR
+1.25%
$5.63
SOUN
-4.35%
$18.23
BTBT
-8.29%
$3.87
VALE
-1.14%
$11.27
BBD
-2.36%
$3.30
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
MARA
-3.18%
$20.07
IREN
-6.79%
$55.19
RMBL
+60.50%
$3.21
DCGO
+24.16%
$1.49
HAL
+11.58%
$25.24
CJET
-20.45%
$0.08
AAL
+1.47%
$12.35
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
CLSK
-7.99%
$18.77
NOK
-2.27%
$5.58
DFLI
-3.96%
$1.21
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
AMC
+4.33%
$2.89
KO
+4.06%
$71.22
PBR
-1.11%
$11.56
SNAP
+1.55%
$7.85
ONDS
-7.46%
$7.19
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
SMCI
-0.39%
$54.82
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.83%
$152.00
RIVN
+0.91%
$13.20
GOOG
-2.20%
$251.34
PLTR
-0.04%
$181.51
BAC
-0.99%
$51.52
APLD
-9.35%
$32.54
EPWK
-8.71%
$0.07
RGTZ
+15.11%
$15.61
ETWO
0.00%
$3.30
MSN
+59.31%
$0.76
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
WTO
+2.93%
$0.06
KVUE
-0.20%
$14.93
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.